Julia F Simard1,2,3, Elizabeth V Arkema3, Cathina Nguyen1, Elisabet Svenungsson4, Anna-Karin Wikström3,5, Kristin Palmsten6, Jane E Salmon7. 1. Division of Epidemiology, Department of Health Research and Policy, Stanford School of Medicine, Stanford, CA. 2. Division of Immunology and Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA. 3. Clinical Epidemiology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden. 4. Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden. 5. Department of Clinical Sciences, Karolinska Institute, Danderyd Hospital, Stockholm, Sweden. 6. Department of Pediatrics, University of California, San Diego, La Jolla, CA. 7. Division of Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY.
Abstract
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that occurs during childbearing years and has been associated with preeclampsia. However, little is known about preeclampsia of early onset, which is associated with severe adverse maternal and perinatal outcomes. METHODS: Using national population-based Swedish registers we identified women with SLE (≥2 visits with corresponding ICD codes) and a sample without SLE who gave birth to singleton infants 2001-12. Risk ratios (RR) and 95% confidence intervals (CI) for early-onset preeclampsia (defined by ICD codes corresponding to preeclampsia registered at <34 weeks) in SLE women were calculated based on adjusted modified Poisson models for first, subsequent, and all pregnancies. RESULT: Among 742 births to women with SLE and 10 484 births to non-SLE women, there were 32 (4.3%) and 55 (0.5%) diagnoses of early-onset preeclampsia respectively. SLE was associated with an increased risk of early-onset preeclampsia (RR 7.8, 95% CI 4.8, 12.9, all pregnancies). The association remained similar upon restriction to women without pregestational hypertension. Adjustment for antiphospholipid syndrome (APS)-proxy attenuated the association. RRs for early-onset preeclampsia were smaller for subsequent pregnancies (RR 4.7, 95% CI 2.0, 11.2) compared to first and all (see above). CONCLUSION: Women with SLE are at increased risk of early-onset preeclampsia and this increased risk may be independent of the traditional risk factors such as pregestational hypertension, APS, BMI, or smoking. Women with SLE during pregnancy should be closely monitored for early-onset preeclampsia and future research needs to identify the non-traditional preeclampsia factors that might cause this serious outcome.
BACKGROUND:Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that occurs during childbearing years and has been associated with preeclampsia. However, little is known about preeclampsia of early onset, which is associated with severe adverse maternal and perinatal outcomes. METHODS: Using national population-based Swedish registers we identified women with SLE (≥2 visits with corresponding ICD codes) and a sample without SLE who gave birth to singleton infants 2001-12. Risk ratios (RR) and 95% confidence intervals (CI) for early-onset preeclampsia (defined by ICD codes corresponding to preeclampsia registered at <34 weeks) in SLEwomen were calculated based on adjusted modified Poisson models for first, subsequent, and all pregnancies. RESULT: Among 742 births to women with SLE and 10 484 births to non-SLEwomen, there were 32 (4.3%) and 55 (0.5%) diagnoses of early-onset preeclampsia respectively. SLE was associated with an increased risk of early-onset preeclampsia (RR 7.8, 95% CI 4.8, 12.9, all pregnancies). The association remained similar upon restriction to women without pregestational hypertension. Adjustment for antiphospholipid syndrome (APS)-proxy attenuated the association. RRs for early-onset preeclampsia were smaller for subsequent pregnancies (RR 4.7, 95% CI 2.0, 11.2) compared to first and all (see above). CONCLUSION:Women with SLE are at increased risk of early-onset preeclampsia and this increased risk may be independent of the traditional risk factors such as pregestational hypertension, APS, BMI, or smoking. Women with SLE during pregnancy should be closely monitored for early-onset preeclampsia and future research needs to identify the non-traditional preeclampsia factors that might cause this serious outcome.
Authors: Jill P Buyon; Mimi Y Kim; Marta M Guerra; Carl A Laskin; Michelle Petri; Michael D Lockshin; Lisa Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Lamya Garabet; Jane E Salmon Journal: Ann Intern Med Date: 2015-08-04 Impact factor: 25.391
Authors: Danieli Andrade; Mimi Kim; Luz P Blanco; S Ananth Karumanchi; Gloria C Koo; Patricia Redecha; Kyriakos Kirou; Angela M Alvarez; Melissa J Mulla; Mary K Crow; Vikki M Abrahams; Mariana J Kaplan; Jane E Salmon Journal: Arthritis Rheumatol Date: 2015-04 Impact factor: 10.995
Authors: Elizabeth V Arkema; Kristin Palmsten; Christopher Sjöwall; Elisabet Svenungsson; Jane E Salmon; Julia F Simard Journal: Arthritis Care Res (Hoboken) Date: 2016-07 Impact factor: 4.794
Authors: K D Kolstad; J A Mayo; L Chung; Y Chaichian; V M Kelly; M Druzin; D K Stevenson; G M Shaw; J F Simard Journal: BJOG Date: 2019-10-31 Impact factor: 6.531
Authors: K J Gray; V P Kovacheva; H Mirzakhani; A C Bjonnes; B Almoguera; M L Wilson; S A Ingles; C J Lockwood; H Hakonarson; T F McElrath; J C Murray; E R Norwitz; S A Karumanchi; B T Bateman; B J Keating; R Saxena Journal: BJOG Date: 2020-09-14 Impact factor: 6.531
Authors: Lenka Vokalova; Shane V van Breda; Xi Lun Ye; Evelyn A Huhn; Nandor G Than; Paul Hasler; Olav Lapaire; Irene Hoesli; Simona W Rossi; Sinuhe Hahn Journal: Front Endocrinol (Lausanne) Date: 2018-09-21 Impact factor: 5.555